Oral Delivery of Large Molecules
Oral Delivery of Large Molecules
Home
About Us
Company Profile
Strategy
Management Team
Board of Directors
Technology
Oral Drug Delivery
Parathyroid Hormone
Supportive Publications
Pipeline
Progress Summary
Hypoparathyroidism
Osteoporosis
Bone Healing
News and Events
News
Events
Investors
Contact Us
Oral Delivery of Large Molecules
Sitemap
Main Menu
Home
About Us
Strategy
Management Team
Dr. Phillip Schwartz President of R&D and Executive Vice President
Dr. Hillel Galitzer – COO
Dr. Arthur Santora - CMO
Dr. Roger Garceau - Interim CEO
Dana Yaacov-Garbeli, CPA, - Israel CFO.
Jonathan Lieber US CFO
Board of Directors
Mr. Zeev Bronfeld
Dr. Roger Garceau
Mr. Gerald Lieberman - Chairman of the Board
Mr. Yonatan Malca
Dr. Phillip Schwartz
Faith L. Charles
Miranda J. Toledano
Mr. Gerald M. Ostrov
Technology
Parathyroid Hormone
Pipeline
Hypoparathyroidism
Overview
Market
Current Status
Osteoporosis
Overview
Market
Current Status
Bone Healing
Overview
Market
Current Status
Events
ASBMR 2012
ASBMR 2013
ASBMR 2014
ASBMR 2015
ASMBR 2016
ASMBR 2017
ASMBR 2018
ASMBR 2019
Contact Us
bottom Menu
Sitemap